Timo Laitio
MD, PhD
Div. of Perioper Services, Intensive Care Med and Pain Manag titala@utu.fi |
Intensive care medicine; pharmacological neuroprotection; cardioprotection; risk stratification
- Spoken words are processed during dexmedetomidine-induced unresponsiveness (2018)
- British Journal of Anaesthesia
- Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest The Xe-Hypotheca Trial (2017)
- Journal of the American College of Cardiology
- Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial (2017)
- JAMA: Journal of the American Medical Association
- A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trial (2016)
- Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial (2016)
- JAMA: Journal of the American Medical Association
- Osteointegration of PLGA implants with nanostructured or microsized β-TCP particles in a minipig model (2014)
- Journal of the Mechanical Behavior of Biomedical Materials
- Sleep apnoea is associated with major cardiac events in peripheral arterial disease (2014)
- European Respiratory Journal
- White matter damage of the brain is associated with poor outcome in vascular surgery patients with claudication: a pilot study (2014)
- European Journal of Vascular and Endovascular Surgery
- Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest (2013)
- Critical Care Medicine
- Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease (2013)
- European Respiratory Journal



